GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹196 Cr | ₹146 Cr | ₹137 Cr | - | - |
What is the latest Long Term Provisions ratio of GLAND PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹196 Cr |
| Mar2025 | ₹146 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | - |
| Mar2022 | - |
How is Long Term Provisions of GLAND PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹196 Cr | 34.01 | |
| Mar2025 | ₹146 Cr | 6.40 | |
| Mar2024 | ₹137 Cr | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Long Term Provisions of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹50,594.8 Cr | 3.5% | 5.6% | 61.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 3.5% |
5.6% |
61.5% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses